(Q36209906)

12 August 2017

1 reference

title

Invasive group A streptococcal disease: should close contacts routinely receive antibiotic prophylaxis? (English)

1 reference

12 August 2017

A Smith

1

1 reference

12 August 2017

T L Lamagni

2

1 reference

12 August 2017

I Oliver

3

1 reference

12 August 2017

A Efstratiou

4

1 reference

12 August 2017

R C George

5

1 reference

12 August 2017

J M Stuart

6

1 reference

12 August 2017

publication date

1 August 2005

1 reference

Lancet Infectious Diseases

12 August 2017

published in

1 reference

12 August 2017

volume

5

1 reference

12 August 2017

issue

8

1 reference

12 August 2017

page(s)

494-500

1 reference

Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

The Serological Classification of Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

A serological differentiation of human and other groups of hemolytic streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Invasive group A streptococcal infections: the past, present and future.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Streptococcal serogroup A epidemic in Norway 1987-1988.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Group A streptococci in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Invasive group A streptococcal infections in the San Francisco Bay area, 1989-99.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Group A Streptococcal Infections in Sweden: A Comparative Study of Invasive and Noninvasive Infections and Analysis of Dominant T28 emm28 Isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

A cluster of cases of streptococcal necrotizing fasciitis in Gloucestershire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Increasing incidence of group A streptococcal infections amongst injecting drug users in England and Wales.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Invasive group A streptococcal disease: risk factors for adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Risk factors for invasive group A streptococcal infections in children with varicella: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Group A Streptococcus carriage among close contacts of patients with invasive infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Transmission of Streptococcus pyogenes causing successive infections in a family

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Risk for Severe Group A Streptococcal Disease among Patients’ Household Contacts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Transmission of Streptococcus pyogenes causing toxic shock-like syndrome among family members and confirmation by DNA macrorestriction analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Familial transmission of a serious disease--producing group A streptococcus clone: case reports and review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

The role of household contacts in the transmission of group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

A family cluster of five cases of group A streptococcal pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

A new system for grading recommendations in evidence based guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Clindamycin treatment of chronic pharyngeal carriage of group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Prevention of Invasive Group A Streptococcal Disease among Household Contacts of Case Patients and among Postpartum and Postsurgical Patients: Recommendations from the Centers for Disease Control and Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

A family cluster of streptococcal toxic shock syndrome in children: clinical implication and epidemiological investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Prevention of rheumatic fever; treatment of the preceding streptococcic infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Penicillin in the treatment of streptococcal infections; a comparison of effectiveness of five different oral and one parenteral form

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Antibiotic management of group A streptococcal pharyngotonsillitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Macrolides in the management of streptococcal pharyngitis/tonsillitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Paediatric safety of azithromycin: worldwide experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Evaluation of short-course therapy with cefixime or rifampin for eradication of pharyngeally carried group A streptococci. The Ontario GAS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

Rifampin resistance in Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970190-0

7 January 2021

10.1016/S1473-3099(05)70190-0

Identifiers

DOI

1 reference

12 August 2017

1 reference